Noom Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: people who want GLP-1s, brand or compounded, paired with Noom's psychology-based habit app and coaching
Noom scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Price checked on Noom's site,
What the monthly price covers
Medication
Not stated
Provider visits
Included
Shipping
Not stated
Lab work
Not stated
Coaching
Included
No insurance needed · Vetted by our editors
Behavioral weight-loss app that also prescribes GLP-1s. Its GLP-1Rx Program (medication included) is $129 to start, then $249 a month billed quarterly; brand Zepbound is self-pay through LillyDirect on top of the $129/mo Noom Med fee.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Noom
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Noom at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $249/mo (3-month plan rate)
- What's included
- Consult · Coaching
- FDA status
- No FDA warning letter on record
How we scored Noom
Each dimension is scored algorithmically from Noom'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.2/10Noom's headline is $249 a month on a 3-month plan. Compare it with other programs on the same plan basis.
Effectiveness25%
8.4/10Noom offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
7.1/10Online intake and platform experience (consult included in the price); 2 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.1/10Noom's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
7.2/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Noom review
Last checked November 2026- Confirmed current pricing across 2 dose/plan tiers and 1 separate fee
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $179–$249/mo across 2 dose/plan tiers, plus a $299/mo fee that excludes the medication (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Noom
We walked Noom's public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Take a quick quiz to customize the program.
- 2A medical clinician evaluates eligibility.
- 3Clinician prescribes a GLP-1 if clinically appropriate.
- 4Medication is shipped to your door.
- Pricing shown up front: the GLP-1Rx Program is $129 to start, then $249/mo billed quarterly; the Microdose plan is $79, then $179/mo.
- Medication 'shipped to your door in just 7 days'; availability varies and not available in all 50 states.
- Support via 24/7 live-agent chat and email; phone noted as under maintenance.
- Excludes users under 18, pregnant individuals, those with eating disorders, or BMI below 18.5.
- No refund/cancellation policy stated on the page reviewed.
GLP-1 medications Noom offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$129 for the first 4-week supply, then $249 a month billed quarterly. Includes medication, clinical care and the Noom program.
Noom's Zepbound page: 'self-pay Zepbound® vials starting at $299/mo', fulfilled through LillyDirect. Medication only: the Noom Med subscription ('$39 to get started, then $129/month for ongoing care') is billed separately and 'The cost of medication is not included in the Noom Med subscription.'
$79 for the first 4-week supply, then $179 a month billed quarterly, not month to month.
Ready to get started?
Plans and promotions change often, so check Noom's current pricing and active discounts before you decide.
What we like
- Both semaglutide and tirzepatide available
Watch-outs
- After the first 4 weeks, medication plans are billed quarterly, not month to month
Noom Med: the weight-loss app that grew a prescription pad
Most people meet Noom long before they think about a GLP-1. It started as the psychology-driven food-logging app with the cheerful color-coded meals and the daily coaching nudges, and that history is the single most important thing to understand about it. Noom Med is the clinical add-on bolted onto a behavior-change platform, not a standalone telehealth pharmacy. If you want a medication and nothing else, Noom is an odd fit. If you want a semaglutide or tirzepatide prescription wrapped inside a structured habit program you'll use, that combination is what it's built to sell.
What you can be prescribed
Noom Med is unusually broad on the medication side. Noom's GLP-1 page lists the full slate of brand-name GLP-1s (Wegovy, Zepbound, Ozempic, and Mounjaro), plus the oral Wegovy pill and plain metformin for people who want to start gentler or cheaper. On top of that it offers a compounded "Microdose GLP-1" track and a separate brand-name access path. That's a wider menu than many app-first competitors, which tend to push one compounded formulation and call it a day. Noom also owns OpenRx, a separate brand that sells prescription peptides such as NAD+ and sermorelin rather than GLP-1s.
- Brand-name injectables: Wegovy, Zepbound, Ozempic, Mounjaro
- Oral options: the Wegovy pill and metformin
- Compounded route: a low-dose "Microdose GLP-1" plan as a lower-cost entry point
How the pricing works: three paths, billed quarterly
Noom publishes its prices on a pricing page, and the cost depends on which path you pick. The GLP-1Rx Program is $129 for the first 4-week supply, then $249 a month, with medication, clinical care and the app included. The Microdose plan is $79 to start, then $179 a month. Both are billed quarterly after the first four weeks, so you pay three months at a time rather than month to month. The brand-name route works differently: Noom Med is $39 to start and $129 a month for care, and the medication is extra. Self-pay Zepbound vials through LillyDirect start at $299 a month on top of that fee.
For context, the category median sits around $179 a month. Noom's GLP-1Rx Program costs more than that, and the brand route adds the care fee to the drug price. Compare the all-in figure for your path against a flat-rate competitor, and see our scoring methodology for how we weigh price.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.
The coaching is the differentiator, not the pharmacy
Strip away the medication and what's left is still a serious product, and that's the point. Every medication plan includes full access to the core Noom app, plus what the company describes as on-demand one-to-one support and coaching and unlimited chat with its doctors. For someone who has rebounded after past diets, that wraparound (the logging, the lessons, the human in your pocket when a craving hits at nine at night) is the reason to pick Noom over a bare-bones script mill. The drug suppresses appetite, and the app is supposed to rebuild the habits so the loss sticks when you eventually taper off.
Who should choose Noom, and who should walk
Choose Noom if you're a mainstream patient who wants the medication and the behavioral scaffolding in one subscription, and who finds app-based accountability helpful. It's a comfortable on-ramp for first-timers who'd rather not assemble a clinic, a coach, and a pharmacy separately.
- Good fit: people who want medication plus structured habit coaching, GLP-1 first-timers, anyone who already likes the Noom app
- Poor fit: price-shoppers who want to pay month to month at a below-median rate; people who only want a prescription with no app or coaching attached; anyone who dislikes daily-engagement programs. If you live in Texas and paying with no contract matters more to you, VitaFusions IV charges one price at any dose with no membership or autodraft, though it has no online checkout
Trust, oversight, and the gaps
Noom carries no FDA warning letters, and it's a large, well-known consumer-health company rather than a fly-by-night brand. Both are points in its favor. But two gaps keep it out of the top tier. First, it does not publicly disclose which states it serves; its fine print says only that it is not available in all 50 states, so confirm coverage in your own state before assuming you can sign up. When confirmed 50-state coverage is your priority, Nucore Health is a physician-owned, LegitScript-certified clinic serving every state, though its prices sit behind an intake quiz. Second, the plans bill quarterly after the first four weeks, which locks in three months of cost at a time. Neither is a safety red flag, but both are friction you should know about going in.
The bottom line
Noom Med is a credible, broad-menu GLP-1 option whose main value is the behavior-change program around the prescription, not a bargain price. If you want the app-plus-medication bundle and you're willing to confirm your state and total cost yourself before paying, it's a reasonable mainstream pick. If you just want the cheapest transparent script, a flat-rate cash-pay competitor will serve you better. Check the current price for your specific plan on Noom's pricing page before you commit, since Noom has changed these numbers before.
The Bottom Line
Noom scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Noom?
From $249 a month on a 3-month plan. See current pricing and start your online intake.
Head-to-head
Compare Noom vs…
Noom scores7.1/10
Side-by-side pricing, medications and scores. Pick a matchup.
Noom vs Amazon One Medical
Amazon One Medical scores 8.5/10

Noom vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Noom review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See Noom's current pricing
Plans from $249 a month on a 3-month plan. Start the online intake to check eligibility and today's price.